Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies.
Yamamura Y, Koyama N, Umehara K.
Xenobiotica · journal article · DOI 10.3109/00498254.2014.985760 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för chlorzoxazone. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
11 hitsPharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
Kwon MH, Lee CJ, Cho YY, Kang HE.
J Pharm Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.18433/j3dw3sEffect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
Feil K, Claaßen J, Bardins S, Teufel J, Krafczyk S, Schneider E, Schniepp R, Jahn K, Kalla R, Strupp M.
Neurology · research support, non-u.s. gov't; journal article · DOI 10.1212/wnl.0b013e3182a55f6dChlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats.
Hopf FW, Simms JA, Chang SJ, Seif T, Bartlett SE, Bonci A.
Biol Psychiatry · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.biopsych.2010.11.011A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N, Wittayalertpanya S, Komolmit P.
J Med Assoc Thai · research support, non-u.s. gov't; journal articleChlorzoxazone inhibits contraction of rat thoracic aorta.
Dong DL, Luan Y, Feng TM, Fan CL, Yue P, Sun ZJ, Gu RM, Yang BF.
Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2006.06.063In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment.
Lee AM, Yue J, Tyndale RF.
Drug Metab Dispos · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.106.010363Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: crystallographic and computational analyses of inhibitor potency.
Rosenfeld RJ, Garcin ED, Panda K, Andersson G, Aberg A, Wallace AV, Morris GM, Olson AJ, Stuehr DJ, Tainer JA, Getzoff ED.
Biochemistry · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1021/bi026313jChlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E.
Hum Exp Toxicol · journal article · DOI 10.1191/096032701682692937Stimulation of Cl(-) secretion by chlorzoxazone.
Singh AK, Devor DC, Gerlach AC, Gondor M, Pilewski JM, Bridges RJ.
J Pharmacol Exp Ther · comparative study; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-3565(24)35351-0Pharmacokinetics of chlorzoxazone in humans.
Desiraju RK, Renzi NL, Nayak RK, Ng KT.
J Pharm Sci · journal article · DOI 10.1002/jps.2600720905